Literature DB >> 282074

Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.

G Leonetti, L Terzoli, C Sala, C Bianchini, L Sernesi, A Zanchetti.   

Abstract

1. The pressor role of renin stimulated by chronic diuretic therapy has been assessed in 31 patients with essential hypertension by infusing the angiotensin II antagonist, saralasin, immediately before and at the end of 2 weeks' treatment with the diuretic, chlorthalidone. 2. Under diuretic therapy the change in blood pressure caused by saralasin was found to be correlated to plasma renin activity values, in such a way that small pressor responses were again observed in patients whose renin was mildly stimulated by the diuretic, whereas a marked depressor response occurred in patients whose renin was markedly increased. 3. On the other hand, the hypotensive effect of chlorthalidone was correlated to values of plasma renin activity under diuretic therapy in an opposite direction: indeed little or no decrease and sometimes an increase in blood pressure were observed in patients with marked renin activation by diuretic therapy. 4. It is concluded that stimulation of renin release by chronic diuretic therapy can be considered a factor limiting the hypotensive activity of diuretic drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282074     DOI: 10.1042/cs055307s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  8 in total

Review 1.  The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years.

Authors:  A G Dupont
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

2.  Haemodynamic profile of captopril treatment in various forms of hypertension.

Authors:  J H de Bruyn; A J Man in't Veld; G J Wenting; F H Derkx; M A Schalekamp
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension.

Authors:  J C Roos; P Boer; H A Koomans; G G Geyskes; E J Dorhout Mees
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.

Authors:  A Salvetti; R Pedrinelli; G Bartolomei; M A Cagianelli; G Cinotti; P Innocenti; C Loni; G Saba; P Saba; L Papi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.

Authors:  A Lechi; S Pomari; R Berto; P Buniotto; A Parrinello; F Marini; L Cogo; A Tomasi; G Baretta
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 6.  Captopril and hydrochlorothiazide: rationale for their combination.

Authors:  E Ambrosioni; C Borghi; F V Costa
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

7.  Captopril plus hydrochlorothiazide once daily normalizes 24 h blood pressure in patients with essential hypertension.

Authors:  J L Meijer; H G Ardesch; J C Van Rooijen; J H De Bruijn
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

8.  Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.

Authors:  G A MacGregor; N D Markandu; R A Banks; J Bayliss; J E Roulston; J C Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.